Michishige Terasaki

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

Masaharu Nagashima, Takuya Watanabe, Michishige Terasaki et al. · Diabetologia · 2011 · 241 citations · Full text

A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis

Yuko Tashiro, Kengo Sato, Takuya Watanabe et al. · Peptides · 2014 · 143 citations

Inflammation, Anti-inflammatory, Granulocyte +7

Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice

Michishige Terasaki, Munenori Hiromura, Yusaku Mori et al. · PLoS ONE · 2015 · 107 citations · Full text

Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice

Yukinori Nogi, Masaharu Nagashima, Michishige Terasaki et al. · PLoS ONE · 2012 · 87 citations · Full text

Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice

Michishige Terasaki, Masaharu Nagashima, Kyoko Nohtomi et al. · PLoS ONE · 2013 · 68 citations · Full text